CLL Support Association
8,892 members14,210 posts

AACR Results Of Single Agent Ibrutinib from Dr. Wiestner of the NIH

The press release of Dr. Wiestner of the NIH on the one year data on single agent ibrutinib with no other drugs to help in 17p del and > 65 patients, with my commentary:

Bottom line: 94% event free survival at one year. WOW!

You may also like...